This text is a result of machine translation.
Shuidi company has established a new pharmaceutical innovation division to further develop the pharmaceutical direction
Biotech Firm ImmuneOnco Submitted Listing Application on the Main Board of HKEX
ImmuneOnco, focusing on developing new-generation tumor immunotherapeutic, will further accelerate the development of other promising drug candidates targeting checkpoints of innate and adaptive immunity.
Yesterday 10:58 PM
360 DigiTech: A Leader in an Oscillating Market
360 DigiTech's core competencies of asset-light model and technology focus offer a bright future. In the first quarter of 2022, the firm outperformed its competitors in terms of user amount, total loans granted and revenue. However, it operates in a market that has been performing below expectations as risks mount and profitability decreases.
Jun 25, 2022 10:00 AM
Bai chongen: it is suggested to use the price mechanism to distribute electricity and distribute the carbon emission quota to end users
A Closer Look at China’s Cloud Service Market, Guessing Who Will Succeed? [1/2]
Jun 27, 2022 05:09 PM
Exclusive Interview with Xu Qian, Managing Partner of Redhill Capital
Jun 27, 2022 12:24 PM